- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06271187
Dynamische ortheseprogramma's voor slaghandfunctie
Ontwikkeling van innovatieve modulaire 3D-geprinte dynamische orthesen: toepassingsprogramma's voor handfunctiefacilitatie bij patiënten met een beroerte
This study aims to investigate the training benefits of modular 3D printed dynamic orthoses on upper limb function in stroke survivors.
Studie Overzicht
Toestand
Conditie
Interventie / Behandeling
Gedetailleerde beschrijving
This study is a randomized controlled intervention trial. Participants are recruited from two medical centers in Taiwan and undergo a continuous 6-week intervention for post-stroke movement rehabilitation. The control group receives traditional stroke occupational therapy rehabilitation. The experimental group, in addition to traditional treatment, supplements their therapy with the use of modular 3D printed dynamic orthoses developed by the research team for home training. Both groups undergo two effectiveness follow-up assessments, one month and two months after the intervention.
Studietype
Inschrijving (Werkelijk)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Taiwan
-
Tainan, Taiwan, Taiwan, 701
- National Cheng Kung University
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion criteria:
- Onset of stroke at least three months ago;
- Upper limb Brunnstrom stage II~IV;
- Shoulder can actively flex at least 45 degrees.
Exclusion criteria:
- Affected hand has regained autonomous grasping function, able to grasp and release a tennis ball 10 times within 2 minutes;
- Joint deformity or stiffness in the affected hand that prevents the use of the dynamic orthosis;
- Diagnosis of other neurological disorders affecting motor control, such as neglect, Parkinson's disease, etc.;
- Inability to follow therapist guidance;
- Currently undergoing other specific treatments affecting motor function recovery (such as rTMS and BTX).
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Geen (open label)
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Dynamic-orthosis training group
Participants will undergo traditional occupational therapy (2-3 times per week, one hour per session, for a total of six weeks), supplemented with an additional home-based dynamic orthotic therapy program (five days per week, one hour per session, for six weeks). The style of the dynamic orthosis will be selected by the researchers based on the participants' movement performance and rehabilitation goals, and it will be adjusted or replaced as their abilities progress. |
Engaging in motion training at home with the use of dynamic orthoses. Traditional post-stroke movement training arranged by an occupational therapist in a medical setting. |
|
Ander: Regular training group
Participants will receive traditional occupational therapy (2-3 sessions per week, one hour per session, for a total of six weeks). The training program includes muscle strength training, reaching and grasping exercises, manual tone control, motor facilitation, and activities of daily living training. During the study period, participants will not wear any hand dynamic orthosis during training. |
Traditional post-stroke movement training arranged by an occupational therapist in a medical setting. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Fugl-Meyer Assessment- Upper Extremity
Tijdsspanne: Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
The Fugl-Meyer Assessment-Upper Extremity (FMA-UE) is a specialized test designed for evaluating motor function in individuals post-stroke. It employs an ordinal scale to score 33 items related to upper limb movements, with a total score of 66 points. Each item reflects movements indicative of motor function in post-stroke hemiparetic patients, covering a range from proximal to distal joints. The FMA-UE has undergone extensive testing and has been found to possess excellent psychometric properties. It is considered an effective assessment tool for upper limb motor function, particularly suitable for chronic stroke patients with moderate to severe impairments. |
Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
|
Box and Block Test
Tijdsspanne: Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
The Box and Block Test (BBT) is a tool used to assess manual dexterity, known for its short assessment time, simplicity, and ease of understanding. It exhibits excellent test-retest reliability (0.96) and inter-rater reliability (0.99). The test involves counting the number of cubes a person can move within one minute, with a higher quantity indicating better functionality. The size of the cubes is 2.5cm³, and there are a total of 150 cubes. Past research suggests a Minimal Clinically Important Difference (MCID) value of 5.5 cubes for the BBT. |
Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
|
Motor Activity Log
Tijdsspanne: Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
The Motor Activity Log (MAL) is a questionnaire-based assessment that evaluates the amount of use (AOU) and quality of movement (QOM) of the affected side in daily activities. The scoring for amount of use ranges from 0 (never using the affected hand in the activity) to 5 (always using the affected hand in the activity). Quality of movement is scored from 0 (unable to use the affected hand) to 5 (movement quality comparable to pre-stroke). There are a total of 28 items in the assessment, recording the average scores for both amount of use and movement quality for each item. Previous research has demonstrated good construct validity for this scale, with a Minimal Clinically Important Difference (MCID) ranging from 1.0 to 1.1 points. |
Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Modified Ashworth scale
Tijdsspanne: Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
The MAS (Modified Ashworth Scale) utilizes quick stretching to assess muscle tone, with testing conducted on the upper limb, specifically the hand, elbow, wrist, and fingers. For ease of statistical analysis, the scale is converted into numerical values ranging from 0 to 5, with lower scores indicating lower muscle tone. |
Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
|
Upper limb joint range of motion
Tijdsspanne: Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
This study will use a goniometer to measure the upper limb joint range of motion in patients, including the shoulder, elbow, wrist, and fingers. The measurements encompass passive range of motion (PROM), active range of motion without wearing orthosis (AROM), and active-assisted range of motion with orthosis assistance (AAROM). |
Pre-test(Week 0), post-test(Week 6), follow-up assessment(Week 10 & Week 14)
|
Medewerkers en onderzoekers
Medewerkers
Onderzoekers
- Hoofdonderzoeker: JERHAO CHANG, PhD, National Cheng Kung University
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Werkelijk)
Studie voltooiing (Werkelijk)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- A-ER-110-507
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .